Early In Vivo Testing to Assess New Therapeutic Interventions in CF Patients

E-ISSN： 1873-4286|18|5|663-673

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.5, 2012-02, pp. : 663-673

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Foreword (“New Targets and New Drugs: from in silico Planning to in vivo Testing”)

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 5, 2013-06 ,pp. : 475-476

Bentham Science Publishers

Access to resources Recommend Favorite

Sodium Channel Blocking Activity and In-vivo Testing of New Phenylimidazole Derivatives

Letters in Drug Design & Discovery, Vol. 13, Iss. 9, 2016-11 ,pp. : 962-967

Bentham Science Publishers

Access to resources Recommend Favorite

Potential therapeutic interventions for hyperglycaemia

Inpharma, Vol. 1, Iss. 1367, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

From Molecular Footprints of Disease to New Therapeutic Interventions in Diabetic Nephropathy: A Detective Story

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 3, 2005-01 ,pp. : 323-329

Bentham Science Publishers

Access to resources Recommend Favorite

The role of early in vivo toxicity testing in drug discovery toxicology

By Fielden Mark R Kolaja Kyle L

Expert Opinion on Drug Safety, Vol. 7, Iss. 2, 2008-03 ,pp. : 107-110

Informa Healthcare

Access to resources Recommend Favorite